Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The host response to urinary tract infection.

Björn Wullt1, G Bergsten, H Fischer

  • 1Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Sölvegatan 23, Lund 223 62, Sweden. bjorn.wullt@urokir.lu.se

Infectious Disease Clinics of North America
|July 10, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulation therapy offers new molecular strategies to treat UTI.

Nature reviews. Urology·2022
Same author

Immunomodulation-A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?

European urology open science·2021
Same author

Active bacterial modification of the host environment through RNA polymerase II inhibition.

The Journal of clinical investigation·2020
Same author

Biomarkers in urinary tract infections - which ones are suitable for diagnostics and follow-up?

GMS infectious diseases·2020
Same author

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019
Same author

Fimbriae reprogram host gene expression - Divergent effects of P and type 1 fimbriae.

PLoS pathogens·2019

This study reveals genetic and molecular factors influencing urinary tract infection (UTI) susceptibility and severity. Understanding host responses can lead to better diagnosis and targeted therapies for recurrent UTIs and kidney scarring.

Area of Science:

  • Urology
  • Infectious Diseases
  • Immunology

Background:

  • Urinary tract infections (UTIs) exhibit significant population-level variability in susceptibility.
  • Understanding host responses is crucial for elucidating disease pathogenesis and developing targeted therapies.
  • Pathologic host responses can be linked to specific disease states, such as acute pyelonephritis with renal scarring.

Purpose of the Study:

  • To identify basic mechanisms of UTI pathogenesis, host response induction, and defense.
  • To provide molecular and genetic explanations for UTI susceptibility.
  • To offer precise diagnostic and therapeutic tools for UTIs.

Main Methods:

  • Utilizing a urinary tract infection (UTI) model.
  • Investigating host response pathways.

Related Experiment Videos

  • Analyzing molecular and genetic factors related to UTI susceptibility.

    • Main Results:

    • Distinct molecular defects identified as causes of acute pyelonephritis with renal scarring.
    • Genetic basis suggested for UTI susceptibility in specific patient groups.
    • Signal transduction pathways linked to symptom development and potential defects in Asymptomatic Bacteriuria (ABU).

    Conclusions:

    • Host response parameters may aid in early detection of patients susceptible to recurrent UTIs and renal scarring.
    • Identifying susceptible patients allows for therapies to enhance defense and close surveillance.
    • Future diagnostics may incorporate host response data for improved UTI management.